blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2678052

EP2678052 - JAB1 BLOCKING COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.08.2019
Database last updated on 28.05.2024
FormerThe patent has been granted
Status updated on  24.08.2018
FormerGrant of patent is intended
Status updated on  28.05.2018
FormerExamination is in progress
Status updated on  31.03.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Emory University
Office of Technology Transfer 1599 Clifton Road, NE 4th Floor
Atlanta, GA 30322 / US
For all designated states
United States Government as represented by the Department of Veterans Affairs
810 Vermont Avenue, NW
Washington, DC 20420 / US
[2018/39]
Former [2014/40]For all designated states
Emory University
Office of Technology Transfer 1599 Clifton Road, NE 4th Floor
Atlanta, GA 30322 / US
For all designated states
United States Government as represented by the Department of Veterans Affairs
810 Vermont Avenue, NW
Washington, DC 20420 / US
Former [2014/01]For all designated states
Emory University
Office of Technology Transfer 1599 Clifton Road, NE 4th Floor
Atlanta, GA 30322 / US
Inventor(s)01 / BODEN, Scott, D.
2842 Cravey Drive
Atlanta, GA 30345 / US
02 / SANGADALA, Sreedhara
18 Fairview Drive
Dallas, GA 30157 / US
 [2014/01]
Representative(s)Coles, Andrea Birgit, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2018/39]
Former [2014/01]Lau, Sarah Jane, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date12748998.723.02.2012
[2018/39]
WO2012US26248
Priority number, dateUS201161446198P24.02.2011         Original published format: US 201161446198 P
[2014/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012116137
Date:30.08.2012
Language:EN
[2012/35]
Type: A2 Application without search report 
No.:EP2678052
Date:01.01.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 30.08.2012 takes the place of the publication of the European patent application.
[2014/01]
Type: B1 Patent specification 
No.:EP2678052
Date:26.09.2018
Language:EN
[2018/39]
Search report(s)International search report - published on:KR03.01.2013
(Supplementary) European search report - dispatched on:EP15.10.2014
ClassificationIPC:A61L27/40, A61L27/54, A61L27/52, A61L27/46
[2014/46]
CPC:
A61L27/54 (EP,US); A61L27/46 (EP,US); A61L2300/414 (EP,US);
A61L2430/02 (EP,US); A61L2430/06 (EP,US)
C-Set:
A61L27/46, C08L89/06 (EP,US)
Former IPC [2014/01]A61L27/54, A61L27/52, A61L27/24, A61L27/12, A61F2/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:JAB1-BLOCKIERUNGSZUSAMMENSETZUNGEN FÜR VERKNÖCHERUNGEN UND ENTSPRECHENDE VERFAHREN[2014/01]
English:JAB1 BLOCKING COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO[2014/01]
French:COMPOSITIONS ANTAGONISTES DE JAB1 POUR OSSIFICATION ET PROCÉDÉS ASSOCIÉS À CELLES-CI[2014/01]
Entry into regional phase19.09.2013National basic fee paid 
19.09.2013Search fee paid 
19.09.2013Designation fee(s) paid 
19.09.2013Examination fee paid 
Examination procedure19.09.2013Examination requested  [2014/01]
11.05.2015Amendment by applicant (claims and/or description)
03.04.2017Despatch of a communication from the examining division (Time limit: M04)
26.07.2017Reply to a communication from the examining division
23.11.2017Despatch of a communication from the examining division (Time limit: M02)
25.01.2018Reply to a communication from the examining division
29.05.2018Communication of intention to grant the patent
17.08.2018Fee for grant paid
17.08.2018Fee for publishing/printing paid
17.08.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.04.2017
Opposition(s)27.06.2019No opposition filed within time limit [2019/36]
Fees paidRenewal fee
27.02.2014Renewal fee patent year 03
26.02.2015Renewal fee patent year 04
26.02.2016Renewal fee patent year 05
27.02.2017Renewal fee patent year 06
27.02.2018Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.02.2012
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
MK26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
MT23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
[2022/31]
Former [2021/32]HU23.02.2012
AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
MT23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2021/26]AL26.09.2018
AT26.09.2018
CY26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
MT23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/29]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
MT23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/17]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
TR26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/12]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/09]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
IE23.02.2019
LU23.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/04]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
LU23.02.2019
CH28.02.2019
LI28.02.2019
Former [2019/50]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SI26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
LU23.02.2019
Former [2019/47]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
LU23.02.2019
Former [2019/45]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
MC26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/34]AL26.09.2018
AT26.09.2018
CZ26.09.2018
DK26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/26]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
SM26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
PT26.01.2019
Former [2019/23]AL26.09.2018
AT26.09.2018
CZ26.09.2018
EE26.09.2018
ES26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
SK26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/22]AL26.09.2018
CZ26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
PL26.09.2018
RO26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/21]AL26.09.2018
FI26.09.2018
HR26.09.2018
IT26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
IS26.01.2019
Former [2019/20]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
NL26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/12]AL26.09.2018
FI26.09.2018
HR26.09.2018
LT26.09.2018
LV26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/11]FI26.09.2018
HR26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/10]FI26.09.2018
LT26.09.2018
RS26.09.2018
SE26.09.2018
BG26.12.2018
NO26.12.2018
GR27.12.2018
Former [2019/08]FI26.09.2018
LT26.09.2018
NO26.12.2018
Former [2019/07]LT26.09.2018
Documents cited:Search[A]US6037519  (MCKAY WILLIAM F [US]) [A] 1-15* column 1 - column 4, line 25; claim - *;
 [Y]US2003144178  (UCKUN FATIH M [US]) [Y] 1-9,11-14 * paragraph [0008] - paragraph [0009] * * paragraph [0024] - paragraph [0029] *;
 [XY]US2009054313  (MARX JEFFREY C [US], et al) [X] 10,15 * paragraph [0002] - paragraph [0013] * * paragraph [0041] * * paragraph [0118] - paragraph [0119]; examples 23-25,27, 28 * * claims 1,6,7,8,29,30 * [Y] 1-9,11-14;
 [AD]  - STEPHANOS IOANNIDIS ET AL, "Discovery of 5-Chloro- N 2 -[(1 S )-1-(5-fluoropyrimidin-2-yl)ethyl]- N 4 -(5-methyl-1 H -pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway", JOURNAL OF MEDICINAL CHEMISTRY, (20110113), vol. 54, no. 1, doi:10.1021/jm1011319, ISSN 0022-2623, pages 262 - 276, XP055144995 [AD] 1,2,9,11,13 * page 262, paragraph 1 - paragraph 2; figures 1,2 *

DOI:   http://dx.doi.org/10.1021/jm1011319
International search[A]US2002193883  (WIRONEN JOHN F [US]);
 [A]US2009054313  (MARX JEFFREY C [US], et al);
 [A]US2010029675  (HWANG SOO-IN [US]);
 [A]US2010068204  (TSOU HWEI-RU [US], et al);
 [A]WO2010044753  (UNIV SINGAPORE [SG], et al)
by applicantUS4877864
 US5013649
 US5661007
 US5688678
 US6177406
 US6369086
 US6369087
 US6372778
 US6372733
 US6432919
 US6534268
 US6858431
 US2009054313
    - HAAG; AIGNER, Arthritis & Rheumatism, (20060000), vol. 54, no. 12, pages 3878 - 3884
    - HAAG; AIGNER, ARTHRITIS & RHEUMATISM, (20060000), vol. 54, no. 12, pages 3878 - 3884
    - WAN et al., EMBO Rep., (20020000), vol. 3, no. 2, pages 171 - 6
    - MADRID et al., Bioorg. Med. Chem. Lett., (20050000), vol. 15, pages 1015 - 1018
    - HWANG et al., J. Med. Chem., (20110000), vol. 54, no. 20, pages 7084 - 7093
    - FELTS et al., Bioorg Med Chem Lett., (20090000), vol. 19, no. 23, pages 6623 - 6626
    - WOZNEY, J. M. et al., Science, (19880000), vol. 242, no. 4885, pages 1528 - 1534
    - IMAI, "Human carboxylesterase isozymes: catalytic properties and rational drug design", Drug Metab Pharmacokinet, (20060000), vol. 21, no. 3, doi:doi:10.2133/dmpk.21.173, pages 173 - 85, XP002530608

DOI:   http://dx.doi.org/10.2133/dmpk.21.173
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.